144 related articles for article (PubMed ID: 34495482)
21. Microsatellite Instability-high Intrahepatic Cholangiocarcinoma with Portal Vein Tumor Thrombosis Successfully Treated with Pembrolizumab.
Naganuma A; Sakuda T; Murakami T; Aihara K; Watanuki Y; Suzuki Y; Shibasaki E; Masuda T; Uehara S; Yasuoka H; Hoshino T; Kudo T; Ishihara H; Ogawa T; Kitamoto Y; Ogawa A
Intern Med; 2020 Sep; 59(18):2261-2267. PubMed ID: 32536644
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic undifferentiated carcinoma with osteoclast-like giant cells curatively resected after pembrolizumab therapy for lung metastases: a case report.
Obayashi M; Shibasaki Y; Koakutsu T; Hayashi Y; Shoji T; Hirayama K; Yamazaki M; Takayanagi Y; Shibata H; Nakamura M; Maruo H
BMC Gastroenterol; 2020 Jul; 20(1):220. PubMed ID: 32652936
[TBL] [Abstract][Full Text] [Related]
23. [Effective chemotherapy with bevacizumab/FOLFOX4 for neuroendocrine carcinoma of the ascending colon - a case study].
Tanabe H; Takase T; Morimoto D; Tanaka Y; Shibata A; Yaguchi T
Gan To Kagaku Ryoho; 2014 May; 41(5):661-4. PubMed ID: 24917018
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
Marabelle A; Le DT; Ascierto PA; Di Giacomo AM; De Jesus-Acosta A; Delord JP; Geva R; Gottfried M; Penel N; Hansen AR; Piha-Paul SA; Doi T; Gao B; Chung HC; Lopez-Martin J; Bang YJ; Frommer RS; Shah M; Ghori R; Joe AK; Pruitt SK; Diaz LA
J Clin Oncol; 2020 Jan; 38(1):1-10. PubMed ID: 31682550
[TBL] [Abstract][Full Text] [Related]
25. Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.
O'Neil BH; Wallmark JM; Lorente D; Elez E; Raimbourg J; Gomez-Roca C; Ejadi S; Piha-Paul SA; Stein MN; Abdul Razak AR; Dotti K; Santoro A; Cohen RB; Gould M; Saraf S; Stein K; Han SW
PLoS One; 2017; 12(12):e0189848. PubMed ID: 29284010
[TBL] [Abstract][Full Text] [Related]
26. First-line pembrolizumab therapy in a cisplatin-ineligible patient with plasmacytoid urothelial carcinoma: A case report.
Hunter L; Moser J; Sturge C; Barraza G; Colonna S
J Oncol Pharm Pract; 2020 Jan; 26(1):216-219. PubMed ID: 30832555
[TBL] [Abstract][Full Text] [Related]
27. Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability.
Yang Y; Jain RK; Glenn ST; Xu B; Singh PK; Wei L; Hu Q; Long M; Hutson N; Wang J; Battaglia S; George S
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221012
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors.
Guo C; Chen X; Xiao W; Wang Q; Sun K; Wang Z
Onco Targets Ther; 2017; 10():1465-1474. PubMed ID: 28331340
[TBL] [Abstract][Full Text] [Related]
29. [Pembrolizumab as first-line therapy in microsatellite instability metastatic colorectal cancers].
Pureur D; Rodrigues M; Turpin A
Bull Cancer; 2021 Mar; 108(3):229-231. PubMed ID: 33632546
[No Abstract] [Full Text] [Related]
30. Eldest gastric cancer patient with high microsatellite instability responding to pembrolizumab.
Wakasugi A; Sasaki A; Okamoto R; Motomura Y
Int Cancer Conf J; 2023 Jan; 12(1):59-62. PubMed ID: 36605839
[TBL] [Abstract][Full Text] [Related]
31. Successful pembrolizumab treatment for microsatellite instability-high thymoma: A case report.
Kaneko T; Sekine A; Komatsu S; Otoshi R; Haga S; Tagami Y; Kaneko T; Ogura T
Respir Investig; 2024 Apr; 62(4):517-519. PubMed ID: 38631274
[TBL] [Abstract][Full Text] [Related]
32. Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden.
Wang VE; Urisman A; Albacker L; Ali S; Miller V; Aggarwal R; Jablons D
J Immunother Cancer; 2017 Sep; 5(1):75. PubMed ID: 28923100
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine carcinoma of the tongue.
Esmati E; Babaei M; Matini A; Ashtiani MS; Hamed EA; Nosrati H; Razi F; Ganjalikhani M
J Cancer Res Ther; 2015; 11(3):659. PubMed ID: 26458666
[TBL] [Abstract][Full Text] [Related]
34. [A Case Report of Neuroendocrine Carcinoma of the Esophagus Treated with Multidisciplinary Therapy].
Sakuratani T; Tanaka Y; Hirata S; Sugiyama T; Tanahashi T; Matsui S; Imai H; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1659-1661. PubMed ID: 29394734
[TBL] [Abstract][Full Text] [Related]
35. Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma.
De Divitiis C; von Arx C; Grimaldi AM; Cicala D; Tatangelo F; Arcella A; Romano GM; Simeone E; Iaffaioli RV; Ascierto PA; Tafuto S;
J Transl Med; 2016 May; 14(1):113. PubMed ID: 27142424
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
37. Mixed adenoneuroendocrine carcinoma of the ampulla of Vater: a case report and literature review.
Yoshimachi S; Ohtsuka H; Aoki T; Miura T; Ariake K; Masuda K; Ishida M; Mizuma M; Hayashi H; Nakagawa K; Morikawa T; Motoi F; Kanno A; Masamune A; Fujishima F; Sasano H; Kamei T; Naitoh T; Unno M
Clin J Gastroenterol; 2020 Feb; 13(1):37-45. PubMed ID: 31342462
[TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine carcinoma of the pancreas with soft tissue metastasis.
Chen J; Zheng Q; Yang Z; Huang XY; Yuan Z; Tang J
World J Gastroenterol; 2012 Dec; 18(45):6682-5. PubMed ID: 23236246
[TBL] [Abstract][Full Text] [Related]
39. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
40. [A case of neuroendocrine carcinoma of the duodenal papilla].
Toshiyama R; Yokoyama S; Hashimoto K; Takeda M; Tokuoka M; Matsuyama J; Ide Y; Morimoto T; Fukushima Y; Nomura T; Kodama K; Shiba I; Takeda M; Sasaki Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1762-4. PubMed ID: 24393914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
